These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 14675858)

  • 21. Effect of torsemide and furosemide on clinical, laboratory, radiographic and quality of life variables in dogs with heart failure secondary to mitral valve disease.
    Peddle GD; Singletary GE; Reynolds CA; Trafny DJ; Machen MC; Oyama MA
    J Vet Cardiol; 2012 Mar; 14(1):253-9. PubMed ID: 22364690
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Torasemide, a new potent diuretic. Double-blind comparison with furosemide.
    Broekhuysen J; Deger F; Douchamps J; Ducarne H; Herchuelz A
    Eur J Clin Pharmacol; 1986; 31 Suppl():29-34. PubMed ID: 3536530
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Torasemide (LUPRAC): a review of its pharmacological and clinical profile].
    Kido H; Ohtaki Y
    Nihon Yakurigaku Zasshi; 2001 Aug; 118(2):97-105. PubMed ID: 11530685
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Loop diuretics enhance the secretion of prostacyclin in vitro, in healthy persons, and in patients with chronic heart failure.
    Liguori A; Casini A; Di Loreto M; Andreini I; Napoli C
    Eur J Clin Pharmacol; 1999 Apr; 55(2):117-24. PubMed ID: 10335906
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Torasemide reduces dilated cardiomyopathy, complication of arrhythmia, and progression to heart failure.
    Han LN; Guo SL; Lin XM; Shi XM; Zang CB; Yang LM; Ding GL
    Genet Mol Res; 2014 Sep; 13(3):7262-74. PubMed ID: 25222231
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In chronic heart failure with marked fluid retention, the i.v. high doses of loop diuretic are a predictor of aggravated renal dysfunction, especially in the set of heart failure with normal or only mildly impaired left ventricular systolic function.
    De Vecchis R; Ciccarelli A; Ariano C; Cioppa C; Giasi A; Pucciarelli A; Cantatrione S
    Minerva Cardioangiol; 2011 Dec; 59(6):543-54. PubMed ID: 21330961
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tolerance of torasemide in cats with congestive heart failure: a retrospective study on 21 cases (2016-2019).
    Poissonnier C; Ghazal S; Passavin P; Alvarado MP; Lefort S; Trehiou-Sechi E; Saponaro V; Barbarino A; Delle Cave J; Marchal CR; Depré B; Vannucci E; Tissier R; Verwaerde P; Chetboul V
    BMC Vet Res; 2020 Sep; 16(1):339. PubMed ID: 32938442
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of torasemide on cardiac sympathetic nerve activity and left ventricular remodelling in patients with congestive heart failure.
    Kasama S; Toyama T; Hatori T; Sumino H; Kumakura H; Takayama Y; Ichikawa S; Suzuki T; Kurabayashi M
    Heart; 2006 Oct; 92(10):1434-40. PubMed ID: 16621879
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative effects of torasemide and furosemide in rats with heart failure.
    Veeraveedu PT; Watanabe K; Ma M; Thandavarayan RA; Palaniyandi SS; Yamaguchi K; Suzuki K; Kodama M; Aizawa Y
    Biochem Pharmacol; 2008 Feb; 75(3):649-59. PubMed ID: 18001696
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Investigating a biomarker-driven approach to target collagen turnover in diabetic heart failure with preserved ejection fraction patients. Effect of torasemide versus furosemide on serum C-terminal propeptide of procollagen type I (DROP-PIP trial).
    Trippel TD; Van Linthout S; Westermann D; Lindhorst R; Sandek A; Ernst S; Bobenko A; Kasner M; Spillmann F; González A; López B; Ravassa S; Pieske B; Paulus WJ; Díez J; Edelmann F; Tschöpe C
    Eur J Heart Fail; 2018 Mar; 20(3):460-470. PubMed ID: 28891228
    [TBL] [Abstract][Full Text] [Related]  

  • 31. LOOP DIURETICS IN HEART FAILURE: EVIDENCE-BASED CHOICE.
    Rоsul ММ; Bletskan ММ; Ivano NV; Korabelschykova MO
    Wiad Lek; 2021; 74(4):1003-1006. PubMed ID: 34156020
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of loop diuretics on myocardial fibrosis and collagen type I turnover in chronic heart failure.
    López B; Querejeta R; González A; Sánchez E; Larman M; Díez J
    J Am Coll Cardiol; 2004 Jun; 43(11):2028-35. PubMed ID: 15172408
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Advantages of the new loop diuretic torasemide over furosemide in patients with cirrhosis and ascites. A randomized, double blind cross-over trial.
    Gerbes AL; Bertheau-Reitha U; Falkner C; Jüngst D; Paumgartner G
    J Hepatol; 1993 Mar; 17(3):353-8. PubMed ID: 8315263
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative effectiveness of loop diuretics on mortality in the treatment of patients with chronic heart failure - A multicenter propensity score matched analysis.
    Täger T; Fröhlich H; Grundtvig M; Seiz M; Schellberg D; Goode K; Kazmi S; Hole T; Katus HA; Atar D; Cleland JGF; Agewall S; Clark AL; Frankenstein L
    Int J Cardiol; 2019 Aug; 289():83-90. PubMed ID: 30827731
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of efficacy and tolerance of different oral doses of torasemide and furosemide in patients with advanced chronic renal failure.
    Kult J; Häcker W; Glocke M
    Arzneimittelforschung; 1988 Jan; 38(1A):212-4. PubMed ID: 3285837
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects.
    Licata G; Di Pasquale P; Parrinello G; Cardinale A; Scandurra A; Follone G; Argano C; Tuttolomondo A; Paterna S
    Am Heart J; 2003 Mar; 145(3):459-66. PubMed ID: 12660669
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Torasemide in advanced renal failure.
    Kindler J
    Cardiovasc Drugs Ther; 1993 Jan; 7 Suppl 1():75-80. PubMed ID: 8435381
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Benefits and risks of torasemide in congestive heart failure and essential hypertension.
    Brater DC
    Drug Saf; 1996 Feb; 14(2):104-20. PubMed ID: 8852525
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Secondary pulmonary hypertension: haemodynamic effects of torasemide versus furosemide.
    von Dossow V; Spies C; Schenk H; Schlesinger S; von Heymann C
    Clin Drug Investig; 2008; 28(1):17-26. PubMed ID: 18081357
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical efficacy of torasemide, a new diuretic agent, in patients with acute heart failure: a double blind comparison with furosemide.
    Stroobandt R; Dodion L; Kesteloot H
    Arch Int Pharmacodyn Ther; 1982 Nov; 260(1):151-8. PubMed ID: 6762167
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.